ECTS / IBMS Training Course – Joints: formation, function and failure with a focus on osteoarthritis
Some of the presentations of the ECTS/IBMS training course are available for you as PDF files.
Katy Schmidt – JOINT DEVELOPMENT DURING EMBRYOGENESIS
George Schett – JOINT TISSUES: CARTILAGE, SYNOVIUM, BONE AND TENDON
Richard Aspden – JOINT FAILURE: BASIC SCIENCE AND BIOMARKERS
Mary Goldring – NOVEL TREATMENTS INCLUDING THE ROLE OF CELL-BASED THERAPIES
John Loughlin – GENETIC RISK FACTORS IN JOINT DISEASE
Saturday 7 May 2011, 09:00-16:30
ECTS/IBMS member € 95
Non-Member € 145
Aims and learning outcomes
By the end of the course participants should have enhanced their understanding of:
the formation and function of joints
joint pathologies and their origin
current and novel approaches to treatment in osteoarthritis
the difficulties in performing trials in this complex disorder and how to overcome these
Who should attend?
This course will be of interest to basic scientists and clinicians with an established interest in joint disorders, as well as those moving into this field. Students and allied health professionals are also warmly invited. While the focus of the clinical and translational part of the course is on osteoarthritis, there are general presentations on joint form and function that will appeal to a much wider audience. The discussion session at the end will also benefit from wider audience participation.
Programme
| 09:00 | REGISTRATION AND COFFEE |
| Session 1: Form and function of joints | |
| 09:30 | JOINT DEVELOPMENT DURING EMBRYOGENESIS |
| Katy Schmidt (Utrecht, Netherlands) | |
| 10:00 | JOINT TISSUES: CARTILAGE, SYNOVIUM, BONE AND TENDON |
| Georg Schett (Erlangen, Germany) | |
| 10:30 | THE JOINT AS AN ORGAN SYSTEM / BIOMECHANICS OF JOINT |
| Georg Duda (Berlin, Germany) | |
| 11:00 | COFFEE BREAK |
| Session 2: Failure of joints in osteoarthritis and current treatment options | |
| 11:30 | JOINT FAILURE: CLINICAL FEATURES OF OSTEOARTHRITIS |
| Stefan Lohmander (Lund, Sweden) | |
| 12:00 | JOINT FAILURE: BASIC SCIENCE AND BIOMARKERS |
| Richard Aspden (Aberdeen, Scotland) | |
| 12:30 | LUNCH |
| 13:30 | NOVEL TREATMENTS INCLUDING THE ROLE OF CELL-BASED THERAPIES |
| Mary Goldring (New York, USA) | |
| 14:00 | DIFFICULTIES WITH CLINICAL TRIALS IN OSTEOARTHRITIS |
| Marie-Pierre Hellio Le Graverand (New London, USA) | |
| 14:30 | COFFEE BREAK |
| Session 3: Looking forward: gene discovery and preclinical studies | |
| 15:00 | GENETIC RISK FACTORS IN JOINT DISEASE |
| John Loughlin (Newcastle, UK) | |
| 15:30 | ANIMAL MODELS FOR PRECLINICAL STUDIES IN JOINT DISEASE |
| Brigitte Mueller-Hilke (Rostock, Germany) | |
| Session 4: The future |
|
| 16:00 | WHAT HAVE WE LEARNED? WHAT DO WE STILL NEED TO KNOW? |
| Discussion session with all speakers | |
| 16:30 | CLOSE |